UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 23, 2004
IT&E International Group
------------------------------------------------------------------------------
(Exact name of registrant specified in charter)
Nevada 000-50095 27-0009939
------------------------------------------------------------------------------
(State of Incorporation) (Commission File Number) (IRS Employer
Identification No.)
31 N. Second Street, Suite 250, San Jose, CA 95113
-------------------------------------------- ----------
(Address of principal executive offices) (zip code)
Issuer's telephone number: (408) 938-1000 Fax number: (408) 947-1816
-------------- --------------
Clinical Trials Assistance Corporation
2078 Redwood Crest, Vista, California 92081-7340
-----------------------------------------------------------------------------
(Former name or former address, if changed since last report)
1
INFORMATION TO BE INCLUDED IN THE REPORT
Item 9. Regulation FD Disclosure.
On June 23, 2004, Clinical Trials Assistance Corporation (the "Company") issued
a press release announcing the Company's name change to IT&E International
Group and a stock symbol change from CTAL to ITER which reflects the Company's
name change. A copy of the press release is attached as Exhibit 99.1 and
incorporated herein by reference.
Exhibit 99.1* - Press Release of Clinical Trials Assistance Corporation,
dated June 23, 2004.
---------------
*Furnished with this document
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: June 23, 2004 IT&E International Group
f/k/a Clinical Trials Assistance Corporation
By: /s/ Peter R. Sollenne
----------------------------------
Name: Peter R. Sollenne
Title: Chief Executive Officer
EXHIBIT INDEX
Exhibit No. Exhibit
----------- -------
99.1 Press Release of Clinical Trials Assistance Corporation,
dated June 23, 2004.